[1] 林远生,邱玉芳,袁小亮. 隐源性机化性肺炎及继发性机化性肺炎的临床特征及影像特点分析[J]. 赣南医学院学报,2019,39(11):1156-1159.
[2] 熊焰. 机化性肺炎的病理学解读[J]. 中国综合临床,2021,37(5):391-394.
[3] Cordier JF. Cryptogenic organizing pneumonia. Clin Chest Med. 2004 Dec;25(4):727-38, vi-vii.
[4] Pathak V, Kuhn JM, Durham C, Funkhouser WK, Henke DC. Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. Ann Am Thorac Soc. 2014 Jan;11(1):87-91.
[5] Lau C, Liang B, Hovsepyan O, Shreves T, Wei K. Scoping review: The state of research on cryptogenic organizing pneumonia therapeutics. Pulm Pharmacol Ther. 2022 Dec;77:102175.
[6] Onishi Y, Kawamura T, Nakahara Y, Kagami R, Sasaki S, Takahashi S, Kominami R, Hirano K, Hiraoka R, Hirata N. Factors associated with the relapse of cryptogenic and secondary organizing pneumonia. Respir Investig. 2017 Jan;55(1):10-15.